JPWO2023102488A5 - - Google Patents
Info
- Publication number
- JPWO2023102488A5 JPWO2023102488A5 JP2024532733A JP2024532733A JPWO2023102488A5 JP WO2023102488 A5 JPWO2023102488 A5 JP WO2023102488A5 JP 2024532733 A JP2024532733 A JP 2024532733A JP 2024532733 A JP2024532733 A JP 2024532733A JP WO2023102488 A5 JPWO2023102488 A5 JP WO2023102488A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- sirna molecule
- represented
- nucleotides
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163284957P | 2021-12-01 | 2021-12-01 | |
| US63/284,957 | 2021-12-01 | ||
| PCT/US2022/080764 WO2023102488A2 (en) | 2021-12-01 | 2022-12-01 | Compositions and methods for treatment of pain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024542738A JP2024542738A (ja) | 2024-11-15 |
| JPWO2023102488A5 true JPWO2023102488A5 (https=) | 2025-12-08 |
| JP2024542738A5 JP2024542738A5 (https=) | 2025-12-08 |
Family
ID=86613161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532733A Pending JP2024542738A (ja) | 2021-12-01 | 2022-12-01 | 疼痛の治療のための組成物及び方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250109402A1 (https=) |
| EP (1) | EP4441228A2 (https=) |
| JP (1) | JP2024542738A (https=) |
| KR (1) | KR20240131349A (https=) |
| CN (1) | CN118632929A (https=) |
| AU (1) | AU2022403005A1 (https=) |
| CA (1) | CA3240948A1 (https=) |
| MX (1) | MX2024006649A (https=) |
| WO (1) | WO2023102488A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025108284A1 (en) * | 2023-11-20 | 2025-05-30 | Shanghai Argo Biopharmaceutical Co., Ltd. | Compositions and methods for inhibiting expression of sodium voltage-gated channel alpha subunit 9 (scn9a) |
| WO2025140551A1 (en) * | 2023-12-29 | 2025-07-03 | Neuro3 Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR TREATING NaV1.7 (SCN9A) -ASSOCIATED DISORDERS |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009033027A2 (en) * | 2007-09-05 | 2009-03-12 | Medtronic, Inc. | Suppression of scn9a gene expression and/or function for the treatment of pain |
-
2022
- 2022-12-01 KR KR1020247021912A patent/KR20240131349A/ko active Pending
- 2022-12-01 CA CA3240948A patent/CA3240948A1/en active Pending
- 2022-12-01 EP EP22902400.5A patent/EP4441228A2/en active Pending
- 2022-12-01 AU AU2022403005A patent/AU2022403005A1/en active Pending
- 2022-12-01 CN CN202280087774.5A patent/CN118632929A/zh active Pending
- 2022-12-01 US US18/714,751 patent/US20250109402A1/en active Pending
- 2022-12-01 JP JP2024532733A patent/JP2024542738A/ja active Pending
- 2022-12-01 MX MX2024006649A patent/MX2024006649A/es unknown
- 2022-12-01 WO PCT/US2022/080764 patent/WO2023102488A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10538763B2 (en) | Compounds and methods for modulation of DUX4 | |
| JP2024056820A (ja) | Ｓｃｎ９ａ発現を調節するためのオリゴヌクレオチド | |
| KR20130069762A (ko) | 안티센스 핵산 | |
| WO2019215175A1 (en) | Oligonucleotides for modulating myh7 expression | |
| KR20200024793A (ko) | 알파-ENaC의 발현을 억제하기 위한 RNAi 작용제 및 사용 방법 | |
| JP2021515784A5 (https=) | ||
| CN104321334A (zh) | 三环核苷及由其制备的低聚化合物 | |
| US20240336919A1 (en) | Rna editing | |
| JPWO2023102488A5 (https=) | ||
| JP2022514648A (ja) | Ｃａｒｄ９を標的とするアンチセンスオリゴヌクレオチド | |
| US20240336920A1 (en) | Threose nucleic acid antisense oligonucleotides and methods thereof | |
| JPWO2022204430A5 (https=) | ||
| JPWO2019175260A5 (https=) | ||
| EP4332221A1 (en) | Threose nucleic acid antisense oligonucleotides and methods thereof | |
| JPWO2022250155A5 (https=) | ||
| US20220204973A1 (en) | Antisense Oligonucleotide for Targeting Progranulin | |
| TW202309286A (zh) | 作為新穎基因靜默技術的非對稱短雙股ｄｎａ及其應用 | |
| JPWO2023102490A5 (https=) | ||
| RU2025110470A (ru) | КОМПОЗИЦИИ миРНК И СПОСОБЫ ДЛЯ НАЦЕЛИВАНИЯ НА НУКЛЕИНОВЫЕ КИСЛОТЫ БЕЛКА ТАУ, АССОЦИИРОВАННОГО С МИКРОТРУБОЧКАМИ | |
| US20250188462A1 (en) | Antisense oligonucleotides for targeting progranulin | |
| JPWO2022256565A5 (https=) | ||
| CA3135794A1 (en) | Angptl2 antisense oligonucleotides and uses thereof | |
| RU2025110478A (ru) | КОМПОЗИЦИИ миРНК И СПОСОБЫ ДЛЯ НАЦЕЛИВАНИЯ НА НУКЛЕИНОВЫЕ КИСЛОТЫ АЛЬФА-СИНУКЛЕИНА | |
| JPWO2019140231A5 (https=) | ||
| WO2023080225A1 (ja) | 脊髄小脳失調症治療用医薬組成物 |